|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 06-30 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| 05-26 | Hologic and Biotheranostics Present New Data on Breast Cancer Index Test At Asco 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16.97B | - | - | - | - | - |
| 191B | |||||
| 143B | |||||
| 137B | - | - | |||
| 64B | |||||
| 52.97B |
- Stock Market
- Stocks
- HOLX Stock
- Charts Hologic, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
